• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗人内源性逆转录病毒-K药物和疫苗,针对肿瘤的潜在疗法。

Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors.

作者信息

Hosseiniporgham Sepideh, Sechi Leonardo Antonio

机构信息

Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.

Unit of Microbiology and Virology, Agency of University Hospital (AOU), 07100 Sassari, Italy.

出版信息

Vaccines (Basel). 2023 Mar 28;11(4):751. doi: 10.3390/vaccines11040751.

DOI:10.3390/vaccines11040751
PMID:37112663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10144246/
Abstract

The footprint of human endogenous retroviruses (HERV), specifically HERV-K, has been found in malignancies, such as melanoma, teratocarcinoma, osteosarcoma, breast cancer, lymphoma, and ovary and prostate cancers. HERV-K is characterized as the most biologically active HERV due to possession of open reading frames (ORF) for all Gag, Pol, and Env genes, which enables it to be more infective and obstructive towards specific cell lines and other exogenous viruses, respectively. Some factors might contribute to carcinogenicity and at least one of them has been recognized in various tumors, including overexpression/methylation of long interspersed nuclear element 1 (LINE-1), HERV-K Gag, and Env genes themselves plus their transcripts and protein products, and HERV-K reverse transcriptase (RT). Therapies effective for HERV-K-associated tumors mostly target invasive autoimmune responses or growth of tumors through suppression of HERV-K Gag or Env protein and RT. To design new therapeutic options, more studies are needed to better understand whether HERV-K and its products (Gag/Env transcripts and HERV-K proteins/RT) are the initiators of tumor formation or just the disorder's developers. Accordingly, this review aims to present evidence that highlights the association between HERV-K and tumorigenicity and introduces some of the available or potential therapies against HERV-K-induced tumors.

摘要

人类内源性逆转录病毒(HERV)的踪迹,特别是HERV-K,已在恶性肿瘤中被发现,如黑色素瘤、畸胎癌、骨肉瘤、乳腺癌、淋巴瘤以及卵巢癌和前列腺癌。HERV-K被认为是生物学活性最强的HERV,因为它拥有所有Gag、Pol和Env基因的开放阅读框(ORF),这使其分别对特定细胞系更具感染性,并对其他外源病毒更具阻碍作用。一些因素可能导致致癌性,并且至少其中之一已在各种肿瘤中得到确认,包括长散在核元件1(LINE-1)、HERV-K Gag和Env基因本身及其转录本和蛋白质产物,以及HERV-K逆转录酶(RT)的过表达/甲基化。对HERV-K相关肿瘤有效的治疗方法大多通过抑制HERV-K Gag或Env蛋白以及RT来靶向侵袭性自身免疫反应或肿瘤生长。为了设计新的治疗方案,需要更多研究来更好地了解HERV-K及其产物(Gag/Env转录本和HERV-K蛋白/RT)是肿瘤形成的引发因素还是仅仅是该病症的发展因素。因此,本综述旨在呈现突出HERV-K与致瘤性之间关联的证据,并介绍一些针对HERV-K诱导肿瘤的现有或潜在治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18f2/10144246/976036a9a5d0/vaccines-11-00751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18f2/10144246/976036a9a5d0/vaccines-11-00751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18f2/10144246/976036a9a5d0/vaccines-11-00751-g001.jpg

相似文献

1
Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors.抗人内源性逆转录病毒-K药物和疫苗,针对肿瘤的潜在疗法。
Vaccines (Basel). 2023 Mar 28;11(4):751. doi: 10.3390/vaccines11040751.
2
HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer.在患有前列腺癌的男性的前列腺癌恶性区域中,HERV-K gag RNA 和蛋白质水平升高。
Viruses. 2021 Mar 10;13(3):449. doi: 10.3390/v13030449.
3
Human endogenous retroviruses and cancer prevention: evidence and prospects.人类内源性逆转录病毒与癌症预防:证据与展望。
BMC Cancer. 2013 Jan 3;13:4. doi: 10.1186/1471-2407-13-4.
4
HERV-K: the biologically most active human endogenous retrovirus family.人内源性逆转录病毒K族:生物学活性最强的人类内源性逆转录病毒家族。
J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S261-7. doi: 10.1097/00042560-199600001-00039.
5
Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.抗人内源性逆转录病毒-K 包膜蛋白抗体在靶向乳腺癌中的免疫治疗潜力。
J Natl Cancer Inst. 2012 Feb 8;104(3):189-210. doi: 10.1093/jnci/djr540. Epub 2012 Jan 12.
6
Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors.人类内源性逆转录病毒HERV-K在人星形细胞瘤中的表达分析
BMC Res Notes. 2014 Mar 19;7:159. doi: 10.1186/1756-0500-7-159.
7
Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses.源自重组杆状病毒的人内源性K型逆转录病毒样颗粒的特性分析
Virology. 1997 Jul 7;233(2):280-91. doi: 10.1006/viro.1997.8614.
8
Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.全基因组筛选、克隆、染色体定位及全长人类内源性K型逆转录病毒的表达
J Virol. 1999 Nov;73(11):9187-95. doi: 10.1128/JVI.73.11.9187-9195.1999.
9
Chromosomal assignment of human endogenous retrovirus K (HERV-K) env open reading frames.人类内源性逆转录病毒K(HERV-K)env开放阅读框的染色体定位
Cytogenet Cell Genet. 1997;79(1-2):157-61. doi: 10.1159/000134709.
10
Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.人内源性逆转录病毒 K 特异性 T 细胞对自体卵巢癌细胞的细胞毒性。
Clin Cancer Res. 2015 Jan 15;21(2):471-83. doi: 10.1158/1078-0432.CCR-14-0388. Epub 2014 Nov 4.

引用本文的文献

1
Human endogenous retrovirus K (HERV-K) envelope structures in pre- and postfusion by cryo-EM.通过冷冻电镜观察人类内源性逆转录病毒K(HERV-K)在融合前和融合后的包膜结构。
Sci Adv. 2025 Aug 29;11(35):eady8168. doi: 10.1126/sciadv.ady8168. Epub 2025 Aug 27.
2
The Role of Human Endogenous Retroviruses in the Initiation and Progression of Melanoma.人类内源性逆转录病毒在黑色素瘤发生和发展中的作用
Biomedicines. 2025 Jul 8;13(7):1662. doi: 10.3390/biomedicines13071662.
3
A Characterization of the Humoral Immune Response to Human Endogenous Retroviruses and in Crohn's Disease.

本文引用的文献

1
Clinical significance of human endogenous retrovirus K (HERV-K) in multiple myeloma progression.人类内源性逆转录病毒K(HERV-K)在多发性骨髓瘤进展中的临床意义。
Int J Hematol. 2023 Apr;117(4):563-577. doi: 10.1007/s12185-022-03513-7. Epub 2022 Dec 16.
2
Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment.具有临床意义的单克隆丙种球蛋白病(MGCS):追求最佳治疗。
Front Immunol. 2022 Nov 23;13:1045002. doi: 10.3389/fimmu.2022.1045002. eCollection 2022.
3
Not all viruses cause disease: HERV-K(HML-2) in healthy human tissues.
克罗恩病中针对人类内源性逆转录病毒的体液免疫反应的特征
Pathogens. 2025 Apr 7;14(4):361. doi: 10.3390/pathogens14040361.
4
: A HERV Turn-On for Autoimmunity, Neurodegeneration, and Cancer?内源性逆转录病毒会引发自身免疫、神经退行性变和癌症吗?
Microorganisms. 2024 Sep 13;12(9):1890. doi: 10.3390/microorganisms12091890.
5
T-cell immunity against senescence: potential role and perspectives.T 细胞对衰老的免疫:潜在作用和展望。
Front Immunol. 2024 Mar 5;15:1360109. doi: 10.3389/fimmu.2024.1360109. eCollection 2024.
6
Human Endogenous Retrovirus-K (HML-2)-Related Genetic Variation: Human Genome Diversity and Disease.人类内源性逆转录病毒-K(HML-2)相关遗传变异:人类基因组多样性与疾病。
Genes (Basel). 2023 Nov 28;14(12):2150. doi: 10.3390/genes14122150.
7
HervD Atlas: a curated knowledgebase of associations between human endogenous retroviruses and diseases.HervD Atlas:一个经过精心策划的人类内源性逆转录病毒与疾病关联知识库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1315-D1326. doi: 10.1093/nar/gkad904.
8
Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions.探讨 HERV-K(HML-2)在癌症中的影响及治疗干预的前景。
Int J Mol Sci. 2023 Sep 27;24(19):14631. doi: 10.3390/ijms241914631.
9
In Vitro Expression Analysis Reveals HML6-c14 to Be an Attractive Research Target.体外表达分析表明 HML6-c14 是一个很有吸引力的研究靶点。
Biomolecules. 2023 Sep 12;13(9):1378. doi: 10.3390/biom13091378.
10
Identification of differentially expressed HERV-K(HML-2) loci in colorectal cancer.结直肠癌中差异表达的人内源性逆转录病毒K(HML-2)基因座的鉴定。
Front Microbiol. 2023 Jun 5;14:1192900. doi: 10.3389/fmicb.2023.1192900. eCollection 2023.
并非所有病毒都会致病:健康人体组织中的 HERV-K(HML-2)。
PLoS Biol. 2022 Oct 31;20(10):e3001884. doi: 10.1371/journal.pbio.3001884. eCollection 2022 Oct.
4
Embryonic and extraembryonic tissues during mammalian development: shifting boundaries in time and space.哺乳动物发育过程中的胚胎和胚外组织:时间和空间上的边界不断变化。
Philos Trans R Soc Lond B Biol Sci. 2022 Dec 5;377(1865):20210255. doi: 10.1098/rstb.2021.0255. Epub 2022 Oct 17.
5
Human Malignant Rhabdoid Tumor Antigens as Biomarkers and Potential Therapeutic Targets.人类恶性横纹肌样瘤抗原作为生物标志物和潜在治疗靶点
Cancers (Basel). 2022 Jul 28;14(15):3685. doi: 10.3390/cancers14153685.
6
p53 Binding Sites in Long Terminal Repeat 5Hs (LTR5Hs) of Human Endogenous Retrovirus K Family (HML-2 Subgroup) Play Important Roles in the Regulation of LTR5Hs Transcriptional Activity.p53 结合位点在人类内源性逆转录病毒 K 家族(HML-2 亚群)的长末端重复 5Hs(LTR5Hs)中发挥重要作用,调节 LTR5Hs 的转录活性。
Microbiol Spectr. 2022 Aug 31;10(4):e0048522. doi: 10.1128/spectrum.00485-22. Epub 2022 Jul 18.
7
Alternative splicing as a source of phenotypic diversity.可变剪接作为表型多样性的一个来源。
Nat Rev Genet. 2022 Nov;23(11):697-710. doi: 10.1038/s41576-022-00514-4. Epub 2022 Jul 12.
8
Effect of human endogenous retrovirus-K env gene knockout on proliferation of ovarian cancer cells.人类内源性逆转录病毒-K 包膜基因敲除对卵巢癌细胞增殖的影响。
Genes Genomics. 2022 Sep;44(9):1091-1097. doi: 10.1007/s13258-022-01280-7. Epub 2022 Jul 8.
9
Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome.全面鉴定和描述人类基因组中的 HERV-K(HML-9)组。
Retrovirology. 2022 Jun 8;19(1):11. doi: 10.1186/s12977-022-00596-2.
10
Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology.人类内源性逆转录病毒 K 与 COVID-19 病理生理学有关。
Microbiome. 2022 Apr 22;10(1):65. doi: 10.1186/s40168-022-01260-9.